Novel therapeutic drug monitoring

September 19, 2008

Email this news item to a friend/colleague

Cranfield University and Sphere Medical Holding PLC are to receive an investment of £322,000 from the Technology Strategy Board to develop a novel drug sensor which will improve the care of critically ill patients by ‘personalising’ their medication.

Each patient’s unique combination of characteristics such as weight, age and gender will affect how drugs perform therapeutically in the body. Therefore it is important that clinicians have the appropriate tools to customise a patient’s medication and achieve optimum uptake.

To meet this need, the industrial-academic team will spend the next few years developing a disposable sensor that can measure drug concentration, detect changes as they happen and provide early detection of any faults in the drug delivery system.

Click here for the press release.